Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2581115 | 0.88 | EPHX1 (0.39) | EPHX1TSHRTAAR1SLC6A2SIGMAR1 | |
| SCHEMBL28990363 | 0.85 | CSNK1E (0.37) | EPHX1TSHRTAAR1SLC6A2SIGMAR1 | |
| SCHEMBL7252952 | 0.79 | EPHX1 (0.55) | EPHX1TSHRTAAR1SLC6A2SIGMAR1 | |
| SCHEMBL9456004 | 0.78 | TDP1 (0.46) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL6682088 | 0.78 | TDP1 (0.46) | EPHX1TSHRTAAR1SLC6A2SIGMAR1 | |
| SCHEMBL106765 | 0.78 | EPHX1 (0.44) | EPHX1TSHRTAAR1SLC6A2SIGMAR1 | |
| SCHEMBL5322507 | 0.77 | SLC6A4 (0.50) | TAAR1SLC6A4CYP1A2CYP2D6ALDH1A1 | |
| Hydrogen Sulfide SCHEMBL9623454 | 0.77 | EPHX1 (0.52) | EPHX1TSHRTAAR1SLC6A2SIGMAR1 | |
| SCHEMBL8746113 | 0.77 | SIGMAR1 (0.46) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL4389864 | 0.77 | TRPA1 (0.45) | EPHX1TSHRTAAR1SLC6A2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024116789-A1 | LUBRICATING OIL COMPOSITION | 出光興産株式会社 | 2024-06-06 | — | — | WO | disclosed |
| WO-2024080214-A1 | METHOD FOR PRODUCING α-OLEFIN POLYMER | 出光興産株式会社 | 2024-04-18 | — | — | WO | disclosed |
| EP-3251678-B1 | BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | ANACOR PHARMACEUTICALS INC (US) | 2021-10-20 | — | — | EP | disclosed |
| US-11008345-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| CN-108610356-B | Benzoxaborole derivatives for the treatment of bacterial infections | 阿纳科制药公司 | 2021-02-26 | — | — | CN | disclosed |
| US-10927078-B2 | Modulators of indoleamine 2,3-dioxygenase | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2021-02-23 | — | — | US | disclosed |
| US-20200165201-A1 | MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2020-05-28 | — | — | US | disclosed |
| EP-3645520-A1 | MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2020-05-06 | — | — | EP | disclosed |
| CN-110709391-A | Modulators of indoleamine2, 3-dioxygenase | 葛兰素史克知识产权开发有限公司 | 2020-01-17 | — | — | CN | disclosed |
| US-20190345173-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, LLC | 2019-11-14 | — | — | US | disclosed |
| EP-1259501-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. Lundbeck A/S (DK) | 2002-11-27 | — | — | EP | disclosed |
| WO-2002076440-A2 | METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES | ELAN PHARMACEUTICALS, INC. (US) | 2002-10-03 | — | — | WO | disclosed |
| US-6420574-B1 | — | — | 2002-07-16 | — | — | US | disclosed |
| US-6420574-B2 | REACTING 1-(4-FLUOROPHENYL)-1,3-DIHYDROISOBENZOFURAN-5-CARBONITRILE WITH SUBSTITUTED ALKYL HALIDE/SULFONATE; CHEMICAL INTERMEDIATE CONVERTED TO AMINE; ANTIDEPRESSANT; AVOIDS BY-PRODUCT FORMATION | H. LUNDBECK A/S (DK) | 2002-07-16 | — | — | US | disclosed |
| US-20010027256-A1 | Method for the preparation of citalopram | H. LUNDBECK A/S (DK) | 2001-10-04 | — | — | US | disclosed |
| WO-2001043525-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. LUNDBECK A/S (DK) | 2001-06-21 | — | — | WO | disclosed |
| EP-1099692-A1 | N,N-SUBSTITUTED CYCLIC AMINE DERIVATIVES | Eisai Co., Ltd. (JP) | 2001-05-16 | — | — | EP | disclosed |
| EP-0863875-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997009311-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1997-03-13 | — | — | WO | disclosed |
| US-5606078-A | ANTIHYPERTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1997-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200165201-A1 | MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | IDO1, IDO2, TPH1 | EPHX1 1420/4885TSHR 2782/4885TAAR1 1418/4885 |
| US-10927078-B2 | Modulators of indoleamine 2,3-dioxygenase | IDO1, IDO2, TPH1 | EPHX1 1420/4885TSHR 2782/4885TAAR1 1418/4885 |
| US-20010027256-A1 | Method for the preparation of citalopram | CRHR1, CRHR2, MC3R | EPHX1 3148/4885TSHR 293/4885TAAR1 220/4885 |
| US-11008345-B2 | Boron-containing small molecules | BCL6B, BTD, BROX | EPHX1 2729/4885TSHR 2857/4885TAAR1 3705/4885 |
| US-20190345173-A1 | BORON-CONTAINING SMALL MOLECULES | BCL6B, BTD, BROX | EPHX1 2729/4885TSHR 2857/4885TAAR1 3705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.